
Joanne Hama
Supervisory Patent Examiner (ID: 14324, Phone: (571)272-2911 , Office: P/1647 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1647, 1632, 4111 |
| Total Applications | 538 |
| Issued Applications | 98 |
| Pending Applications | 74 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5415950
[patent_doc_number] => 20090041837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Aptamers utilized as targeting agents for pharmaceutical compounds used in the treatment of cancer and other diseases'
[patent_app_type] => utility
[patent_app_number] => 12/221430
[patent_app_country] => US
[patent_app_date] => 2008-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3624
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041837.pdf
[firstpage_image] =>[orig_patent_app_number] => 12221430
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/221430 | Aptamers utilized as targeting agents for pharmaceutical compounds used in the treatment of cancer and other diseases | Aug 3, 2008 | Abandoned |
Array
(
[id] => 6443000
[patent_doc_number] => 20100144549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'PARTHENOTE-DERIVED STEM CELLS AND METHODS OF MAKING AND USING THEM'
[patent_app_type] => utility
[patent_app_number] => 12/452750
[patent_app_country] => US
[patent_app_date] => 2008-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32242
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144549.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452750
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452750 | PARTHENOTE-DERIVED STEM CELLS AND METHODS OF MAKING AND USING THEM | Jul 17, 2008 | Abandoned |
Array
(
[id] => 5291175
[patent_doc_number] => 20090023905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Transgenic animal model of bone mass modulation'
[patent_app_type] => utility
[patent_app_number] => 12/216438
[patent_app_country] => US
[patent_app_date] => 2008-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 71975
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023905.pdf
[firstpage_image] =>[orig_patent_app_number] => 12216438
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/216438 | Transgenic animal model of bone mass modulation | Jul 2, 2008 | Abandoned |
Array
(
[id] => 5428107
[patent_doc_number] => 20090087417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'METHODS FOR PROMOTING DOPAMINERGIC NEURONAL DEVELOPMENT BY USING NG4A-SUBFAMILY AND WNT-LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 12/147420
[patent_app_country] => US
[patent_app_date] => 2008-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 24549
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20090087417.pdf
[firstpage_image] =>[orig_patent_app_number] => 12147420
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/147420 | METHODS FOR PROMOTING DOPAMINERGIC NEURONAL DEVELOPMENT BY USING NG4A-SUBFAMILY AND WNT-LIGANDS | Jun 25, 2008 | Abandoned |
Array
(
[id] => 4759386
[patent_doc_number] => 20080311612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Functional Expression of Higher Plant Nitrate Transporters in Pichia Pastoris'
[patent_app_type] => utility
[patent_app_number] => 12/136173
[patent_app_country] => US
[patent_app_date] => 2008-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4753
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311612.pdf
[firstpage_image] =>[orig_patent_app_number] => 12136173
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/136173 | Functional Expression of Higher Plant Nitrate Transporters in Pichia Pastoris | Jun 9, 2008 | Abandoned |
Array
(
[id] => 5349354
[patent_doc_number] => 20090004715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Glycerol Feedstock Utilization for Oil-Based Fuel Manufacturing'
[patent_app_type] => utility
[patent_app_number] => 12/131766
[patent_app_country] => US
[patent_app_date] => 2008-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 49102
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004715.pdf
[firstpage_image] =>[orig_patent_app_number] => 12131766
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/131766 | Glycerol Feedstock Utilization for Oil-Based Fuel Manufacturing | Jun 1, 2008 | Abandoned |
Array
(
[id] => 4778241
[patent_doc_number] => 20080286239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS'
[patent_app_type] => utility
[patent_app_number] => 12/128450
[patent_app_country] => US
[patent_app_date] => 2008-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 33306
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286239.pdf
[firstpage_image] =>[orig_patent_app_number] => 12128450
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/128450 | COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS | May 27, 2008 | Abandoned |
Array
(
[id] => 8951150
[patent_doc_number] => 20130196931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'MEANS AND METHODS FOR COUNTERACTING PROTEIN AGGREGATION'
[patent_app_type] => utility
[patent_app_number] => 12/595658
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15353
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12595658
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595658 | MEANS AND METHODS FOR COUNTERACTING PROTEIN AGGREGATION | Apr 13, 2008 | Abandoned |
Array
(
[id] => 8375178
[patent_doc_number] => 08257969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Genetic suppression and replacement'
[patent_app_type] => utility
[patent_app_number] => 12/595080
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 21
[patent_no_of_words] => 36180
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12595080
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595080 | Genetic suppression and replacement | Apr 13, 2008 | Issued |
Array
(
[id] => 5458242
[patent_doc_number] => 20090258394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'METHOD FOR THE PRODUCTION OF HIGH-LEVEL SOLUBLE HUMAN RECOMBINANT INTERFERON ALPHA IN E. COLI AND VECTORS USEFUL FOR SUCH A PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/100984
[patent_app_country] => US
[patent_app_date] => 2008-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9581
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258394.pdf
[firstpage_image] =>[orig_patent_app_number] => 12100984
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/100984 | METHOD FOR THE PRODUCTION OF HIGH-LEVEL SOLUBLE HUMAN RECOMBINANT INTERFERON ALPHA IN E. COLI AND VECTORS USEFUL FOR SUCH A PRODUCTION | Apr 9, 2008 | Abandoned |
Array
(
[id] => 54579
[patent_doc_number] => 07767879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-03
[patent_title] => 'Transgenic animal model of neurodegenerative disorders'
[patent_app_type] => utility
[patent_app_number] => 12/080985
[patent_app_country] => US
[patent_app_date] => 2008-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10263
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/767/07767879.pdf
[firstpage_image] =>[orig_patent_app_number] => 12080985
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/080985 | Transgenic animal model of neurodegenerative disorders | Apr 6, 2008 | Issued |
Array
(
[id] => 5473708
[patent_doc_number] => 20090246874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Method And Device For Culturing Neural Cells'
[patent_app_type] => utility
[patent_app_number] => 12/055980
[patent_app_country] => US
[patent_app_date] => 2008-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3383
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246874.pdf
[firstpage_image] =>[orig_patent_app_number] => 12055980
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/055980 | Method And Device For Culturing Neural Cells | Mar 25, 2008 | Abandoned |
Array
(
[id] => 5441764
[patent_doc_number] => 20090093403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/041628
[patent_app_country] => US
[patent_app_date] => 2008-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 18203
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093403.pdf
[firstpage_image] =>[orig_patent_app_number] => 12041628
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/041628 | SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS | Mar 2, 2008 | Abandoned |
Array
(
[id] => 4711681
[patent_doc_number] => 20080300207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/040198
[patent_app_country] => US
[patent_app_date] => 2008-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24355
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300207.pdf
[firstpage_image] =>[orig_patent_app_number] => 12040198
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/040198 | Protein production | Feb 28, 2008 | Issued |
Array
(
[id] => 11427833
[patent_doc_number] => 09566135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-14
[patent_title] => 'Method of growing an artery'
[patent_app_type] => utility
[patent_app_number] => 11/986690
[patent_app_country] => US
[patent_app_date] => 2007-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 27
[patent_no_of_words] => 24024
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11986690
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/986690 | Method of growing an artery | Nov 25, 2007 | Issued |
Array
(
[id] => 4820292
[patent_doc_number] => 20080226594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'CULTURING CIRCULAR SSDNA VIRUSES FOR THE PRODUCTION OF VACCINES'
[patent_app_type] => utility
[patent_app_number] => 11/944555
[patent_app_country] => US
[patent_app_date] => 2007-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15836
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226594.pdf
[firstpage_image] =>[orig_patent_app_number] => 11944555
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/944555 | CULTURING CIRCULAR SSDNA VIRUSES FOR THE PRODUCTION OF VACCINES | Nov 22, 2007 | Abandoned |
Array
(
[id] => 42772
[patent_doc_number] => 07781394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Methods for identifying anti-tumor and/or anti-angiogenesis drugs with deoxynucleoside 5′-monophosphate N-glycosidase as the target'
[patent_app_type] => utility
[patent_app_number] => 11/939114
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9063
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/781/07781394.pdf
[firstpage_image] =>[orig_patent_app_number] => 11939114
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/939114 | Methods for identifying anti-tumor and/or anti-angiogenesis drugs with deoxynucleoside 5′-monophosphate N-glycosidase as the target | Nov 12, 2007 | Issued |
Array
(
[id] => 6529878
[patent_doc_number] => 20100015217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Enhancing Pulmonary Host Defense via Administration of Granulocyte-Macrophage Colony Stimulating Factor'
[patent_app_type] => utility
[patent_app_number] => 12/513215
[patent_app_country] => US
[patent_app_date] => 2007-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8105
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015217.pdf
[firstpage_image] =>[orig_patent_app_number] => 12513215
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/513215 | Enhancing Pulmonary Host Defense via Administration of Granulocyte-Macrophage Colony Stimulating Factor | Nov 1, 2007 | Abandoned |
Array
(
[id] => 4859595
[patent_doc_number] => 20080268445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Ant2 Conditional Knockout Mouse and Methods'
[patent_app_type] => utility
[patent_app_number] => 11/871956
[patent_app_country] => US
[patent_app_date] => 2007-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11559
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20080268445.pdf
[firstpage_image] =>[orig_patent_app_number] => 11871956
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/871956 | Ant2 Conditional Knockout Mouse and Methods | Oct 11, 2007 | Abandoned |
Array
(
[id] => 7800914
[patent_doc_number] => 08129184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Cancer stem cell antigen vaccines and methods'
[patent_app_type] => utility
[patent_app_number] => 11/862135
[patent_app_country] => US
[patent_app_date] => 2007-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 37
[patent_no_of_words] => 15720
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/129/08129184.pdf
[firstpage_image] =>[orig_patent_app_number] => 11862135
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/862135 | Cancer stem cell antigen vaccines and methods | Sep 25, 2007 | Issued |